BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Jorge Sahlieh on Adapting Cardinal Health’s Products and Services to Tackle Healthcare's Pressing Financial and Workforce Challenges

In this exclusive interview with BioPharma APAC, Jorge Sahlieh, President of International Medical Products and Distribution at Cardinal Health, sh...

September 12, 2024 | Interview

Inside Asia-Pacific’s Cell and Gene Therapy Evolution: A Conversation with Raymond Chow, VP of Commercial, APAC at Cytiva

In an interaction with BioPharma APAC, Raymond Chow, Vice President of Commercial for Asia-Pacific at Cytiva, shares his insights on the rapidly evolving l...

September 02, 2024 | Interaction

New Trials, New Pills—The Pharma Rollercoaster Continues!

The Landscape of Innovation: A Double-Edged Sword The pace at which pharmaceutical companies are developing new drugs is nothing short of astonish...

August 30, 2024 | Report

Strategic Vision Meets Execution: Glen Godresse's Bold Moves in His First 100 Days as CEO of Menarini Asia-Pacific

In a candid conversation with BioPharma APAC, Glen Godresse, CEO of Menarini Asia-Pacific, reflects on his first 100 days at the helm, highlighting...

August 23, 2024 | Interview

Tackling Dengue: Insights from Leading Experts Amid Surge in Southeast Asia

In an exclusive interview with BioPharma APAC, Professor Ooi Eng Eong, a leading expert in Emerging Infectious Diseases at Duke-NUS Medical School,...

August 22, 2024 | Interview

Driving Healthcare Innovation in Asia: Rehan Saghir of ZP Therapeutics on Pioneering Drug Commercialization and Overcoming Regional Challenges

In an exclusive interview with BioPharma APAC, Rehan Saghir, Executive Vice President of ZP Therapeutics, Zuellig Pharma shares his expert insights...

August 20, 2024 | News

Alexandre de Muralt Discusses Merck's Tailored Strategies in the APAC Region and Commitment to Boosting Fertility Rates, Formed from a Deep Understanding of this Complex Market

In an exclusive interview with BioPharma APAC, Alexandre de Muralt, Senior Vice President of Asia Pacific for Merck’s healthcare business, shares his...

August 20, 2024 | Interview

AI Meets Life Sciences: How HKSTP and BioMap Are Transforming Hong Kong’s Biotech Landscape

In an exclusive interview with BioPharma APAC, Dr. Grace Lau, Head of Institute for Translational Research at Hong Kong Science and Technology Parks Corpor...

August 14, 2024 | Interview

The Critical Role of Chemistry, Manufacturing, and Control (CMC) in Pharmaceutical Product Development

The Development of new pharmaceutical products is a complex and multifaceted process that requires rigorous scientific, technical, and regulatory scrutiny....

August 09, 2024 | Opinion | By Vaibhav Patel, RAC-US, ASQ CQA Director of Quality Assurance and Regulatory Affairs, University of Minnesota

Prof Jeyaraj Pandian Discusses the Rising Stroke Burden in Southeast Asia and Collaborative Efforts for Improved Care

In an interview with BioPharma APAC, Prof Jeyaraj Pandian, President-Elect of the World Stroke Organization, provides an in-depth overview of the c...

August 01, 2024 | Interview

Aptamer Group's CTO Arron Tolley Discusses Strategic Milestones and Innovations in Collaboration with AstraZeneca

In an exclusive interview with BioPharma APAC, Arron Tolley, Chief Technology Officer of Aptamer Group, shares insights on the company's latest col...

July 11, 2024 | News

Advancing Cancer Care: The Promise and Potential of CAR-T Therapy

In an interaction with BioPharma APAC, Anuradha Rajapakse, Senior Director for Value & Access at Gilead and Kite Oncology, This discussion...

June 28, 2024 | Interaction

Unveiling Bio4C™ ProcessPad with Ashok Kumar, Head of BIO4C Commercial at Merck Life Science (Asia Pacific)

In an interview with BioPharma APAC, Ashok Kumar, Head of BIO4C Commercial at Merck Life Science (Asia Pacific), shares insights on what se...

June 24, 2024 | Interaction

APAC Takes Center Stage in Antibody-Drug Conjugate Development, Transforming Cancer Treatment

Antibody-drug conjugates (ADCs) represent a revolutionary class of biopharmaceuticals designed to selectively deliver cytotoxic agents to cancer cells whil...

June 07, 2024 | Report

Stay Connected